Next Article in Journal
Newborn Screening for Sickle Cell Disease: Indian Experience
Next Article in Special Issue
Pulse Oximetry Screening for Critical Congenital Heart Defects: A Life-Saving Test for All Newborn Babies
Previous Article in Journal
The Newborn Hearing Screening Programme in Germany
Previous Article in Special Issue
Pulse Oximetry Screening in Germany—Historical Aspects and Future Perspectives
Open AccessArticle

Pulse Oximetry Values in Newborns with Critical Congenital Heart Disease upon ICU Admission at Altitude

1
Department of Pediatrics, Heart Institute, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA
2
Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
3
Center for Public Health Innovation at CI International, Littleton, CO 80120, USA
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2018, 4(4), 30; https://doi.org/10.3390/ijns4040030
Received: 17 September 2018 / Revised: 25 October 2018 / Accepted: 27 October 2018 / Published: 31 October 2018
(This article belongs to the Special Issue Neonatal Screening for Critical Congenital Heart Defects)
Pulse oximetry screening for critical congenital heart disease (CCHD) has been recommended by the American Academy of Pediatrics (AAP). The objectives of this study are to describe saturation data, and to evaluate the effectiveness of AAP-recommended pulse oximetry screening guidelines applied retrospectively to a cohort of newborns with known CCHD at moderate altitude (5557 feet, Aurora, Colorado). Data related to seven critical congenital heart disease diagnoses were extracted from electronic health records (pulse oximetry, prostaglandin administration, and oxygen supplementation). Descriptive epidemiologic data were calculated. 158 subjects were included in this analysis; the AAP pulse oximetry screening protocol was applied to 149 subjects. Mean pre-ductal and post-ductal pulse oximetry values of the infants known to have CCHD at 24 h of life were 87.1% ± 7.2 and 87.8% ± 6.3, respectively. Infants treated with prostaglandins and oxygen had lower oximetry readings. The screening algorithm would have identified 80.5% of infants with known CCHDs (120/149 subjects). Additionally, sequential pulse oximetry screening based on the AAP-recommended protocol was able to identify a true positive screen capture rate of 80.5% at moderate altitude. View Full-Text
Keywords: critical congenital heart disease; pulse oximetry; newborn screening; altitude critical congenital heart disease; pulse oximetry; newborn screening; altitude
Show Figures

Figure 1

MDPI and ACS Style

Kim, J.S.; Ariefdjohan, M.W.; Sontag, M.K.; Rausch, C.M. Pulse Oximetry Values in Newborns with Critical Congenital Heart Disease upon ICU Admission at Altitude. Int. J. Neonatal Screen. 2018, 4, 30.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop